BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis
Europe - BIT:1BAYN - DE000BAY0017 - Common Stock
26.47 EUR
-0.31 (-1.16%)
Taking everything into account, 1BAYN scores 3 out of 10 in our fundamental rating. 1BAYN was compared to 53 industry peers in the Pharmaceuticals industry. 1BAYN may be in some trouble as it scores bad on both profitability and health. 1BAYN is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year 1BAYN was profitable.
1BAYN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 1BAYN reported negative net income in multiple years.
Each year in the past 5 years 1BAYN had a positive operating cash flow.
1.2 Ratios
1BAYN has a Return On Assets of -3.25%. This is in the lower half of the industry: 1BAYN underperforms 66.04% of its industry peers.
1BAYN has a worse Return On Equity (-11.25%) than 66.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROIC | N/A |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
1BAYN's Operating Margin has declined in the last couple of years.
1BAYN has a worse Gross Margin (54.95%) than 69.81% of its industry peers.
In the last couple of years the Gross Margin of 1BAYN has declined.
1BAYN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
1BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1BAYN remains at a similar level compared to 1 year ago.
The number of shares outstanding for 1BAYN remains at a similar level compared to 5 years ago.
The debt/assets ratio for 1BAYN has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.78, we must say that 1BAYN is in the distress zone and has some risk of bankruptcy.
1BAYN has a Altman-Z score of 0.78. This is in the lower half of the industry: 1BAYN underperforms 71.70% of its industry peers.
The Debt to FCF ratio of 1BAYN is 8.37, which is on the high side as it means it would take 1BAYN, 8.37 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.37, 1BAYN is doing worse than 67.92% of the companies in the same industry.
1BAYN has a Debt/Equity ratio of 1.04. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.04, 1BAYN is doing worse than 67.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Altman-Z | 0.78 |
ROIC/WACCN/A
WACC6.41%
2.3 Liquidity
A Current Ratio of 1.13 indicates that 1BAYN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.13, 1BAYN is doing worse than 67.92% of the companies in the same industry.
A Quick Ratio of 0.73 indicates that 1BAYN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.73, 1BAYN is doing worse than 73.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
1BAYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.36%.
Measured over the past years, 1BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.27% on average per year.
The Revenue has decreased by -1.99% in the past year.
1BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-16.36%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%30.85%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.63%
3.2 Future
The Earnings Per Share is expected to grow by 2.96% on average over the next years.
Based on estimates for the next years, 1BAYN will show a small growth in Revenue. The Revenue will grow by 1.11% on average per year.
EPS Next Y-5.97%
EPS Next 2Y-1.62%
EPS Next 3Y2%
EPS Next 5Y2.96%
Revenue Next Year-1.18%
Revenue Next 2Y-0.09%
Revenue Next 3Y0.7%
Revenue Next 5Y1.11%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 5.28, the valuation of 1BAYN can be described as very cheap.
Based on the Price/Earnings ratio, 1BAYN is valued cheaply inside the industry as 96.23% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of 1BAYN to the average of the S&P500 Index (26.13), we can say 1BAYN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 5.42, the valuation of 1BAYN can be described as very cheap.
1BAYN's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1BAYN is cheaper than 94.34% of the companies in the same industry.
1BAYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.28 | ||
| Fwd PE | 5.42 |
4.2 Price Multiples
71.70% of the companies in the same industry are more expensive than 1BAYN, based on the Enterprise Value to EBITDA ratio.
98.11% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.66 | ||
| EV/EBITDA | 8.8 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.62%
EPS Next 3Y2%
5. Dividend
5.1 Amount
1BAYN has a yearly dividend return of 0.41%, which is pretty low.
Compared to an average industry Dividend Yield of 2.99, 1BAYN is paying slightly less dividend.
With a Dividend Yield of 0.41, 1BAYN pays less dividend than the S&P500 average, which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
5.2 History
The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.69%
EPS Next 2Y-1.62%
EPS Next 3Y2%
BIT:1BAYN (11/5/2025, 7:00:00 PM)
26.47
-0.31 (-1.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.00B
Revenue(TTM)46.17B
Net Income(TTM)-3418000000
Analysts71.43
Price Target29.07 (9.82%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-3.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.87%
Min EPS beat(2)1.86%
Max EPS beat(2)45.89%
EPS beat(4)3
Avg EPS beat(4)8.47%
Min EPS beat(4)-17.26%
Max EPS beat(4)45.89%
EPS beat(8)6
Avg EPS beat(8)3.46%
EPS beat(12)8
Avg EPS beat(12)1.61%
EPS beat(16)12
Avg EPS beat(16)4.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-0.98%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)3
Avg Revenue beat(12)-2.37%
Revenue beat(16)7
Avg Revenue beat(16)-1.04%
PT rev (1m)-1.85%
PT rev (3m)0.79%
EPS NQ rev (1m)-5.78%
EPS NQ rev (3m)-9.06%
EPS NY rev (1m)0%
EPS NY rev (3m)2.93%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.28 | ||
| Fwd PE | 5.42 | ||
| P/S | 0.56 | ||
| P/FCF | 5.66 | ||
| P/OCF | 3.64 | ||
| P/B | 0.86 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.8 |
EPS(TTM)5.01
EY18.93%
EPS(NY)4.89
Fwd EY18.47%
FCF(TTM)4.67
FCFY17.66%
OCF(TTM)7.28
OCFY27.49%
SpS47
BVpS30.91
TBVpS-18.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number59.03
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% | ||
| FCFM | 9.94% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score4
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Debt/EBITDA | 4.79 | ||
| Cap/Depr | 32.07% | ||
| Cap/Sales | 5.54% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 107.94% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 0.78 |
F-Score4
WACC6.41%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.36%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%30.85%
EPS Next Y-5.97%
EPS Next 2Y-1.62%
EPS Next 3Y2%
EPS Next 5Y2.96%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.63%
Revenue Next Year-1.18%
Revenue Next 2Y-0.09%
Revenue Next 3Y0.7%
Revenue Next 5Y1.11%
EBIT growth 1Y-161.08%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.33%
EBIT Next 3Y21.52%
EBIT Next 5Y10.7%
FCF growth 1Y1068.78%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y169.98%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / 1BAYN.MI FAQ
What is the fundamental rating for 1BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to 1BAYN.MI.
What is the valuation status for 1BAYN stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (1BAYN.MI). This can be considered as Undervalued.
Can you provide the profitability details for BAYER AG-REG?
BAYER AG-REG (1BAYN.MI) has a profitability rating of 2 / 10.
What is the earnings growth outlook for BAYER AG-REG?
The Earnings per Share (EPS) of BAYER AG-REG (1BAYN.MI) is expected to decline by -5.97% in the next year.
Is the dividend of BAYER AG-REG sustainable?
The dividend rating of BAYER AG-REG (1BAYN.MI) is 0 / 10 and the dividend payout ratio is -3.69%.